» Articles » PMID: 29145445

A New Approach by Optical Coherence Tomography for Elucidating Biofilm Formation by Emergent Candida Species

Abstract

The majority of microorganisms present a community lifestyle, establishing biofilm ecosystems. However, little is known about its formation in emergent Candida species involved in catheter-related infections. Thus, various techniques may be used in the biofilm detection to elucidate structure and clinical impact. In this context, we report the ability of emergent Candida species (Candida haemulonii, C. lusitaniae, C. pelliculosa, C.guilliermondii, C. famata and C. ciferrii) on developing well structured biofilms with cell viability and architecture, using optical coherence tomography (OCT). This new approach was compared with XTT analyses and Scanning Electron Microscopy (SEM). A positive correlation between oxidative activity (XTT) and OCT results (r = 0.8752, p < 0.0001) was observed. SEM images demonstrated cells attachment, multilayer and morphologic characteristics of the biofilm structure. C. lusitaniae was the emergent species which revealed the highest scattering extension length and oxidative metabolism when evaluated by OCT and XTT methods, respectively. Herein, information on C. ciferri biofilm structure were presented for the first time. The OCT results are independently among Candida strains and no species-specific pattern was observed. Our findings strongly contribute for clinical management based on the knowledge of pathogenicity mechanisms involving emergent yeasts.

Citing Articles

Complex: The Current State of Infections and Drug Resistance in Humans.

Cosio T, Pica F, Fontana C, Pistoia E, Favaro M, Valsecchi I J Fungi (Basel). 2024; 10(4).

PMID: 38667965 PMC: 11050938. DOI: 10.3390/jof10040294.


Effect of Escin Alone or in Combination with Antifungal Agents on Resistant Biofilms: Mechanisms of Action.

Maione A, Imparato M, Galdiero M, de Alteriis E, Feola A, Galdiero E Antibiotics (Basel). 2023; 12(7).

PMID: 37508306 PMC: 10376425. DOI: 10.3390/antibiotics12071210.


Antifungal Effect and Inhibition of the Virulence Mechanism of D-Limonene against .

Leite-Andrade M, de Araujo Neto L, Buonafina-Paz M, de Assis Graciano Dos Santos F, da Silva Alves A, Accioly Brelaz de Castro M Molecules. 2022; 27(24).

PMID: 36558017 PMC: 9788451. DOI: 10.3390/molecules27248884.


: Biology, Pathogenicity, Virulence Factors, Diagnosis, and Treatment.

Mendoza-Reyes D, Gomez-Gaviria M, Mora-Montes H Infect Drug Resist. 2022; 15:5121-5135.

PMID: 36068831 PMC: 9441179. DOI: 10.2147/IDR.S383785.


WMR Peptide as Antifungal and Antibiofilm against Albicans and Non-Albicans Candida Species: Shreds of Evidence on the Mechanism of Action.

Maione A, Bellavita R, de Alteriis E, Galdiero S, Albarano L, La Pietra A Int J Mol Sci. 2022; 23(4).

PMID: 35216270 PMC: 8879636. DOI: 10.3390/ijms23042151.


References
1.
Kullberg B, Arendrup M . Invasive Candidiasis. N Engl J Med. 2015; 373(15):1445-56. DOI: 10.1056/NEJMra1315399. View

2.
Chandra J, Kuhn D, Mukherjee P, Hoyer L, McCormick T, Ghannoum M . Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001; 183(18):5385-94. PMC: 95423. DOI: 10.1128/JB.183.18.5385-5394.2001. View

3.
Silva W, Seneviratne J, Parahitiyawa N, Rosa E, Samaranayake L, Del Bel Cury A . Improvement of XTT assay performance for studies involving Candida albicans biofilms. Braz Dent J. 2009; 19(4):364-9. DOI: 10.1590/s0103-64402008000400014. View

4.
Kojic E, Darouiche R . Candida infections of medical devices. Clin Microbiol Rev. 2004; 17(2):255-67. PMC: 387407. DOI: 10.1128/CMR.17.2.255-267.2004. View

5.
Agin H, Ayhan Y, Devrim I, Gulfidan G, Tulumoglu S, Kayserili E . Fluconazole-, amphotericin-B-, caspofungin-, and anidulafungin-resistant Candida ciferrii: an unknown cause of systemic mycosis in a child. Mycopathologia. 2011; 172(3):237-9. DOI: 10.1007/s11046-011-9418-6. View